These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 4733318)

  • 41. The effect of pyrrolizidine alkaloids (Senecio vulgaris) on the liver mixed-funcion oxidase system.
    Eastman DF; Segall HJ
    Toxicol Lett; 1980 May; 5(6):369-74. PubMed ID: 7394831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of some 6-substituted benzo(a)pyrene derivatives upon liver enzymes and ascorbic acid excretion in mice.
    Dewhurst F; Kitchen DA
    Biochem Pharmacol; 1973 Apr; 22(7):789-96. PubMed ID: 4144234
    [No Abstract]   [Full Text] [Related]  

  • 43. Ethanol and drug metabolism in mouse liver microsomes subsequent to lipid peroxidation-induced destruction of cytochrome P-450.
    Vatsis KP; Kowalchyk JA; Schulman MP
    Biochem Biophys Res Commun; 1974 Nov; 61(1):258-64. PubMed ID: 4155297
    [No Abstract]   [Full Text] [Related]  

  • 44. Influence of pyridine and some pyridine derivatives on spectral properties of reduced microsomes and on microsomal drug metabolizing activity.
    Jonen HG; Hüthwohl B; Kahl R; Kahl GF
    Biochem Pharmacol; 1974 Apr; 23(8):1319-29. PubMed ID: 4824776
    [No Abstract]   [Full Text] [Related]  

  • 45. Changes in the activities of hepatic microsomal enzymes caused by DDT and dieldrin.
    Sell JL; Davison KL
    Fed Proc; 1973 Sep; 32(9):2003-9. PubMed ID: 4725907
    [No Abstract]   [Full Text] [Related]  

  • 46. The mitochondrial role in hepatic cell mixed-function oxidations.
    Schenkman JB; Cinti DL; Moldeus P
    Ann N Y Acad Sci; 1973; 212():420-7. PubMed ID: 4375426
    [No Abstract]   [Full Text] [Related]  

  • 47. [The behavior of mixed function oxidases in the liver of the rat on the first day after ligation of the ductus choledochus].
    Putzki H; Reichert B; Leemhuis B; Muckle L
    Z Exp Chir Transplant Kunstliche Organe; 1990; 23(3):180-2. PubMed ID: 2087830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex-related differences in the impairment of hepatic drug-metabolizing enzymes in rats with adjuvant disease.
    Mathur PP; Carr GS; Smyth RD
    Biochem Pharmacol; 1978 May; 27(9):1379-80. PubMed ID: 697939
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of 6-aminochrysene on liver microsomal enzyme activity.
    Russo R; Bartosek I; Villa S; Guaitani A; Garattini S
    Xenobiotica; 1976 Apr; 6(4):201-5. PubMed ID: 936641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Enzymatic activity in liver microsomes in the rat after administration of phenolic acids].
    Gaillard D; Mitjavila S; Derache R
    Food Cosmet Toxicol; 1974 Jun; 12(3):303-11. PubMed ID: 4442813
    [No Abstract]   [Full Text] [Related]  

  • 51. Induction of liver microsomal drug metabolism in newly-hatched chicks.
    Jondorf WR; MacIntyre DE; Powis G
    Br J Pharmacol; 1973 Mar; 47(3):624P-625P. PubMed ID: 4147194
    [No Abstract]   [Full Text] [Related]  

  • 52. Hepatic drug metabolism and haem biosynthesis in lead-poisoned rats.
    Goldberg A; Meredith PA; Miller S; Moore MR; Thompson GG
    Br J Pharmacol; 1978 Apr; 62(4):529-36. PubMed ID: 656697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of silybin on the hepatic microsomal drug-metabolising enzyme system in the rat.
    Down WH; Chasseaud LF; Grundy RK
    Arzneimittelforschung; 1974 Dec; 24(12):1986-8. PubMed ID: 4218108
    [No Abstract]   [Full Text] [Related]  

  • 54. Instability of mixed function monooxygenases in frozen rat liver.
    Reinke LA; Stohs SJ
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):295-303. PubMed ID: 940961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of cytochrome P-450-dependent aminopyrine N-demethylase in rat brain: comparison with hepatic aminopyrine N-demethylation.
    Marietta MP; Vesell ES; Hartman RD; Weisz J; Dvorchik BH
    J Pharmacol Exp Ther; 1979 Feb; 208(2):271-9. PubMed ID: 33263
    [No Abstract]   [Full Text] [Related]  

  • 56. Post mortem characteristics of the hepatic microsomal drug oxidising enzyme system.
    Macleod SM; Renton KW; Eade NR
    Chem Biol Interact; 1973 Jul; 7(1):29-37. PubMed ID: 4352876
    [No Abstract]   [Full Text] [Related]  

  • 57. Hepatic organelle interaction. 3. Mitochondrial modification of microsomal drug metabolism.
    Moldeus PW; Cha YN; Cinti DL; Schenkman JB
    J Biol Chem; 1973 Dec; 248(24):8574-84. PubMed ID: 4148675
    [No Abstract]   [Full Text] [Related]  

  • 58. Enhancement of microsomal aniline and acetanilide hydroxylation by haemoglobin.
    Jonen HG; Kahl R; Kahl GF
    Xenobiotica; 1976 May; 6(5):307-20. PubMed ID: 820088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nicotinamide-induced hepatic microsomal mixed function oxidase system in rats.
    Kamat JP; Narurkar LM; Mhatre NA; Narurkar MV
    Biochim Biophys Acta; 1980 Feb; 628(1):26-34. PubMed ID: 6444527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Species differences and drug metabolism.
    Flynn EJ; Lynch M; Zannoni VG
    Biochem Pharmacol; 1972 Oct; 21(19):2577-90. PubMed ID: 4145289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.